Gr-1+CD11b+ myeloid cells efficiently home to site of injury after intravenous administration and enhance diabetic wound healing by neoangiogenesis

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 6, 2014, Pages 1194-1202

  Tong, Xiaozhe ^a   Lv, Gang ^a   Huang, Jianhua ^a,b,c   Min, Yongfen ^d   Yang, Li ^d   Lin, Pengnian Charles ^d  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Ningxia People's Hospital   (China)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Diabetic wound healing; Homing; Neoangiogenesis

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR; GR-1 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; EAR; ENZYME IMMUNOASSAY; EXPERIMENTAL DIABETES MELLITUS; FLOW CYTOMETRY; IMMUNOLOGY; INJURIES; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; LEG; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION; WESTERN BLOTTING; WOUND HEALING;

ADMINISTRATION, INTRAVENOUS; ANIMALS; ANTIGENS, CD11B; BLOTTING, WESTERN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; EAR; FLOW CYTOMETRY; IMMUNOENZYME TECHNIQUES; ISCHEMIA; LOWER EXTREMITY; MICE; MICE, INBRED C57BL; MYELOID CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84904766255     PISSN: 15821838     EISSN: 15824934     Source Type: Journal    
DOI: 10.1111/jcmm.12265     Document Type: Article

References (36)

1. Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res. 2012; 49: 35-43.
2. Xu F, Zhang C, Graves DT. Abnormal cell responses and role of TNF-α in impaired diabetic wound healing. Biomed Res Int. 2013; 2013: 754802.
3. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev. 2003; 23: 117-45.
4. O'Loughlin A, Kulkarni M, Creane M, et al. Topical administration of allogeneic mesenchymal stem cells seeded in a collagen scaffold augments wound healing and increases angiogenesis in the diabetic rabbit ulcer. Diabetes. 2013;. doi:10.2337/db12-1822
5. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008; 31: 596-615.
6. Wu Y, Chen L, Scott PG, et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007; 25: 2648-59.
7. Egaña JT, Fierro FA, Krüger S, et al. Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. Tissue Eng Part A. 2009; 15: 1191-200.
8. Lu D, Chen B, Liang Z, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011; 92: 26-36.
9. Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 2006; 124: 175-89.
10. Bailey AS, Willenbring H, Jiang S, et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci USA. 2006; 103: 13156-61.
11. Kim JA, March K, Chae HD, et al. Muscle-derived Gr1(dim)CD11b(+) cells enhance neovascularization in an ischemic hind limb mouse model. Blood. 2010; 11: 1623-6.
12. Huang J, Lv G, Min Y, et al. Intravenous administration of Gr-1+CD11b+ myeloid cells increases neovascularization and improves cardiac function after heart infarction. Int J Cardiol. 2013; 168: 1702-5.
13. Mahdipour E, Charnock JC, Mace KA. Hoxa3 promotes the differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells. Blood. 2011; 117: 815-26.
14. Ljung BM, Mayall B, Lottich C, et al. Cell dissociation techniques in human breast cancer-variations in tumor cell viability and DNA ploidy. Breast Cancer Res Treat. 1989; 13: 153-9.
15. Lin P, Polverini P, Dewhirst M, et al. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth. J Clin Invest. 1997; 100: 2072-8.
16. Abbott JD, Huang Y, Liu D, et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004; 110: 3300-5.
17. Niiyama H, Huang NF, Rollins MD, et al. Murine model of hindlimb ischemia. J Vis Exp. 2009; pii: 1035. Doi: 10.3791/1035
18. Huang J, Inoue M, Hasegawa M, et al. Sendai viral vector mediated angiopoietin-1 gene transfer for experimental ischemic limb disease. Angiogenesis. 2009; 12: 243-9.
19. Piao W, Wang H, Inoue M, et al. Transplantation of Sendai viral angiopoietin-1-modified mesenchymal stem cells for ischemic limb disease. Angiogenesis. 2010; 13: 203-10.
20. Cho CH, Sung HK, Kim KT, et al. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci USA. 2006; 103: 4946-51.
21. Huang J, Nakamura K, Ito Y, et al. Bcl-xL gene transfer inhibits Bax translocation and prolongs cardiac cold preservation time in rats. Circulation. 2005; 112: 76-83.
22. Leor J, Rozen L, Zuloff-Shani A, et al. Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation. 2006; 114: I94-100.
23. Uutela M, Wirzenius M, Paavonen K, et al. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood. 2004; 104: 3198-204.
24. Schruefer R, Lutze N, Schymeinsky J, et al. Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8. Am J Physiol Heart Circ Physiol. 2005; 288: H1186-92.
25. Akashi K, Traver D, Miyamoto T, et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404: 193-7.
26. Wara AK, Croce K, Foo S, et al. Bone marrow-derived CMPs and GMPs represent highly functional proangiogenic cells: implications for ischemic cardiovascular disease. Blood. 2011; 118: 6461-4.
27. Yang L, DeBusk LM, Fukuda K, et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell. 2004; 6: 409-21.
28. Bronte V, Apolloni E, Cabrelle A, et al. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood. 2000; 96: 3838-46.
29. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999; 5: 434-8.
30. Lee SH, Wolf PL, Escudero R, et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med. 2000; 342: 626-33.
31. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10: 858-64.
32. De Falco E, Porcelli D, Torella AR, et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood. 2004; 104: 3472-82.
33. Chen J, Chen J, Chen S, et al. Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice. PLoS ONE. 2012; 7: e50105.
34. Jackson WM, Nesti LJ, Tuan RS. Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med. 2012; 1: 44-50.
35. Sasaki M, Abe R, Fujita Y, et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008; 180: 2581-7.
36. Sorrell JM, Caplan AI. Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther. 2010; 1: 30.